The Full Story
Let's talk about it: Lymphoma
Lymphoma is the most common type of blood cancer. Specifically, lymphoma is a cancer that affects lymphocytes, which are a type of white blood cell. Lymphocytes travel through the blood and lymphatic system to defend the body against foreign invaders like bacteria and viruses. Lymphomas usually develop when a change, or mutation, occurs within a lymphocyte, causing the abnormal cell to replicate faster than, or live longer than, a normal lymphocyte. Like normal lymphocytes, cancerous lymphocytes can travel through the blood and lymphatic system and spread and grow in many parts of the body, including the lymph nodes, spleen, bone marrow, and other organs.
About
The Lymphoma Research Foundation: In 1995 the Lymphoma Research Foundation (LRF) founded the organization and its dual mission: to eradicate lymphoma by sharing research and treatment insights directly with the lymphoma community through national education programs and resources. Through lymphoma-specific research grants and consortia, the LRF seeks to better understand the more than 100 subtypes of lymphoma and support the development of new treatments. The LRF’s focus on supporting early-career scientists ensures the best and brightest remain in the field of lymphoma research so that innovation and progress continue. Simultaneously, the LRF works tirelessly to help patients, survivors caregivers, and families understand their diagnosis and ensure they have access to the support and resources they need.
About
The Paul Foundation: The Foundation believes adolescent and young adult patients with lymphoma are an understudied population that would particularly benefit from increased and better-funded research which may include funding of ongoing lymphoma clinical trials within the National Cancer Institute (NCI) Cancer Cooperative Groups. A request for grant proposals to be awarded by The Foundation was released by the Lymphoma Research Foundation. Those grant proposals will focus on lymphoma research and have a high degree of relevance to research questions pertinent to adolescent and young adult lymphoma. Our mission will: Focus on the diagnosis, treatment and outcomes as they affect adolescent and young patient populations; Further the understanding of lymphoma and/or its diagnosis and treatment in adolescents and young adults.
About
Erase Lymphoma: In 2014, the LRF launched Erase Lymphoma to raise awareness and provide unique support to adolescent and young adult lymphoma (AYA) patients and survivors.
